Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MBX Biosciences (MBX) Share-based Compensation (2023 - 2026)

MBX Biosciences has reported Share-based Compensation over the past 4 years, most recently at $5.5 million for Q1 2026.

  • Quarterly results put Share-based Compensation at $5.5 million for Q1 2026, up 198.21% from a year ago — trailing twelve months through Mar 2026 was $10.2 million (up 144.55% YoY), and the annual figure for FY2025 was $8.7 million, up 66.16%.
  • Share-based Compensation reached $5.5 million in Q1 2026 per MBX's latest filing, up from $2.7 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $5.5 million in Q1 2026 and bottomed at $227000.0 in Q3 2023.
  • Median Share-based Compensation over the past 4 years was $1.3 million (2025), compared with a mean of $1.6 million.
  • The largest annual shift saw Share-based Compensation increased 13.31% in 2025 before it skyrocketed 198.21% in 2026.
  • Over 4 years, Share-based Compensation stood at $1.0 million in 2023, then surged by 46.17% to $1.5 million in 2024, then skyrocketed by 78.49% to $2.7 million in 2025, then skyrocketed by 106.48% to $5.5 million in 2026.
  • Business Quant data shows Share-based Compensation for MBX at $5.5 million in Q1 2026, $2.7 million in Q4 2025, and $1.3 million in Q3 2025.